BRONKOMETER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bronkometer, and when can generic versions of Bronkometer launch?
Bronkometer is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in BRONKOMETER is isoetharine mesylate. There are four drug master file entries for this compound. Additional details are available on the isoetharine mesylate profile page.
Summary for BRONKOMETER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
DailyMed Link: | BRONKOMETER at DailyMed |
US Patents and Regulatory Information for BRONKOMETER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | BRONKOMETER | isoetharine mesylate | AEROSOL, METERED;INHALATION | 012339-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |